山东威高集团医用高分子制品股份有限公司（威高股份，股票代码：01066）于2026年5月6日公告，已在香港联交所场内回购普通股股票24万股，占当日该公司已发行股份（不包括库藏股）总数约0.0054%，每股回购价介乎3.43港元至3.46港元，合计支付约82.62万港元。本次回购完成后，公司已发行股份数目降至4,468,011,924股，库藏股数目增至54,320,400股，总股份数为4,522,332,324股。
该公司称，此次回购基于于2025年5月27日通过的股份回购授权，当前累计回购股份总数达47,672,000股，占购回授权时已发行股份约10.5572%。公司表示，所有回购安排均已遵守香港联合交易所有限公司证券上市规则及相关法律规定。公告由公司秘书黄妙玲签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.